An Effective COVID-19 Vaccine Needs to Engage T Cells.

Sauer, Karsten; Harris, Tim

Sauer, Karsten; Harris, Tim.

Sauer K; Repertoire Immune Medicines, Cambridge, MA, United States.
Harris T; Repertoire Immune Medicines, Cambridge, MA, United States.

Front Immunol ; 11: 581807, 2020.

Article in English | MEDLINE | ID: covidwho-883851

Subject(s)

Betacoronavirus/immunology; CD4-Positive T-Lymphocytes/immunology; CD8-Positive T-Lymphocytes/immunology; Coronavirus Infections/prevention & control; Pandemics/prevention & control; Pneumonia, Viral/prevention & control; Viral Vaccines/immunology; Antibodies, Neutralizing/immunology; Antibodies, Viral/immunology; B-Lymphocytes/immunology; COVID-19; COVID-19 Vaccines; Coronavirus Infections/immunology; Epitopes, B-Lymphocyte/genetics; Epitopes, B-Lymphocyte/immunology; Humans; Pneumonia, Viral/immunology; SARS-CoV-2

Keywords

COVID−19; SARSCoV-2; T cell; epitope; memory; neutralizing antibody; pandemic; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Viral Vaccines / CD4-Positive T-Lymphocytes / Coronavirus Infections / CD8-Positive T-Lymphocytes / Pandemics / Betacoronavirus Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2020 Document Type: Article Affiliation country: Fimmu.2020.581807

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google